richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
Published 5 years ago • 47 plays • Length 1:14
Download video MP4
Download video MP3
Similar videos
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
9:34
regorafenib in colorectal cancer
-
0:43
richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
-
3:10
regorafenib in refractory biliary tract cancer
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
2:55
ksat q&a: doctor discusses colorectal cancer risk factors, prevention screenings
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
1:16
richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
1:12
axel grothey, md, on the use of regorafenib in the management of advanced crc
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
22:30
new directions in targeting angiogenesis for metastatic colorectal cancer
-
8:25
key takeaway 4: second-line regorafenib after tki in hcc
Clip.africa.com - Privacy-policy